Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q4 2016)

As of Dec 31, 2016, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 14, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2016, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q4 2016
39115V101
Great Panther
Sell
-38,300
Q4 2016
A
Agilent Technologies, Inc.
Buy
+753,800
Q4 2016
AA
Alcoa Corporation
Buy - Position Entry
+1,911,296
Q4 2016
AAME
Atlantic American Corporation
Buy
+100
Q4 2016
AAOI
Applied Optoelectronics, Inc.
Buy - Position Entry
+174,100
Q4 2016
AAON
AAON, Inc.
Sell
-14,200
Q4 2016
AAP
Advance Auto Parts Inc.
Buy - Position Entry
+68,950
Q4 2016
AB
AllianceBernstein Holding L.P.
Sell
-96,700
Q4 2016
ABBNY
ABB Ltd.
Buy - Position Entry
+294,800
Q4 2016
ABBV
AbbVie Inc.
Sell
-1,567,656
Q4 2016
ABCB
Ameris Bancorp
Sell
-28,600
Q4 2016
ABEV
Ambev S.A.
Buy
+4,248,580
Q4 2016
ABG
Asbury Automotive Group Inc
Sell - Position Exit
-7,400
Q4 2016
ABR
Arbor Realty Trust
Buy
+247,500
Q4 2016
ABT
Abbott Laboratories
Buy
+2,323,100
Q4 2016
ABUS
Arbutus Biopharma Corporation
Sell
-102,026
Q4 2016
AC
Associated Capital Group, Inc.
Buy - Position Entry
+87,801
Q4 2016
ACCO
Acco Brands Corporation
Buy
+404,800
Q4 2016
ACHC
Acadia Healthcare Company, Inc.
Buy - Position Entry
+970,500
Q4 2016
ACIC
American Coastal Insurance Corp
Sell
-77,300
Q4 2016
ACLS
Axcelis Technologies, Inc.
Sell
-100,399
Q4 2016
ACM
AECOM
Buy - Position Entry
+822,977
Q4 2016
ACN
Accenture plc
Buy
+213,410
Q4 2016
ACNB
ACNB Corporation
Buy
+5,000
Q4 2016
ACNT
Ascent Industries Co.
Buy
+8,200
Q4 2016
ACRE
Ares Commercial Real Estate Cor
Sell
-169,063
Q4 2016
ACRS
Aclaris Therapeutics, Inc.
Buy - Position Entry
+174,600
Q4 2016
ACTG
Acacia Research Corporation
Buy
+418,500
Q4 2016
ACU
Acme
Buy
+2,000
Q4 2016
ADAP
Adaptimmune Therapeutics plc
Buy
+116,400
Page 1 of 63